news—05.18.2026

Clarion Partners Executes $1 Billion in Strategic Healthcare Real Estate Transactions

Press Release

Image of a multi-story senior living community

​​​- ​​​Series of high-quality acquisitions expands Clarion’s footprint in senior housing, outpatient medical, and inpatient rehabilitation amid historically strong demand​ -

NEW YORK, NY – May 18, 2026 – Clarion Partners, LLC (“Clarion”), a leading real estate investment manager and partially owned subsidiary of Franklin Templeton, has announced that it has recently executed on more than a dozen highly curated single-asset healthcare investments totaling over $1 billion.

The transactions expand Clarion’s national healthcare footprint and deepen its relationships with established operators in key growth markets. They also underscore Clarion’s continued conviction in the healthcare real estate sector, supported by favorable demographic trends and resilient demand for the essential services delivered within these assets, in both residential and retail formats.

Clarion’s high-caliber healthcare real estate portfolio now includes:

  • ~2000 units across well-appointed senior housing communities, acquired through Core, Core-Plus, and Value-Add execution profiles in partnership with six best-in-class operators.
  • 133K sq. ft. of newly delivered or recently renovated medical real estate, offering inpatient rehabilitation and outpatient medical services in partnership with PAM Health and Baylor Scott & White.
  • A growing pipeline of senior housing ground-up developments in strategic, high-growth, and defensible markets, in partnership with best-in-class developers and operators.

The Firm now collectively oversees more than $4.6B healthcare-related assets, including ~2.5 million sq. ft. of well-located Life Science assets secured by long-term leases to prominent pharmaceutical companies.

“We are pleased to have completed these acquisitions, reflecting our disciplined investment approach and deep sector expertise,” said Clarion President Josh Pristaw. “Healthcare real estate continues to present compelling opportunities, particularly in senior housing and post-acute care, where demographic trends and evolving patient needs are driving long-term demand. We believe these properties are well positioned to deliver durable income and attractive risk-adjusted returns for our investors.”

Recent deals have involved maintaining or onboarding leading senior housing operators including Experience Senior Living, MorningStar Senior Living, Stellar Living, Vitality Living, Clearwater Living, and MBK Senior Living.

“Partnering and growing with a select number of experienced, reliable operators is core to Clarion’s senior living strategy,” said Clarion Head of Healthcare Julie Robinson. “We are pleased to have strong working relationships with this group of high-quality partners.”

Robinson adds, “We remain highly active in evaluating and executing on those assets with the best risk-adjusted returns within the healthcare investment landscape, and we continue to see a robust pipeline of opportunities aligned with our investment criteria.”

Clarion Partners recently published two papers explaining their thesis for the healthcare category, which can be accessed here: A Golden Opportunity for Senior Housing and Healthcare Real Estate: Positioning for the Outpatient Era​.​​

​​Watch Clarion's Senior Housing video​ and Investing in Medical Real Estate​ video​ to learn more. ​

​​​

Definitions

Footnotes

Disclosures

Get in touch

We're here to answer your questions.

Contact us

Our offices

  • New York (HQ)
  • Boston
  • Chicago
  • Dallas
  • Los Angeles
  • London
  • Amsterdam
  • Frankfurt
  • Jersey
  • Madrid
  • Paris

Investment in real estate is speculative and involves significant risk. For more information about certain of the material risks and limitations associated with Clarion Partners’ investment advisory products, strategies and services, please see Clarion’s current Form ADV Part 2A brochure, which is available on the SEC’s Investment Adviser Public Disclosure website at https://adviserinfo.sec.gov/firm/summary/108803. Investors should consider their investment objectives, and it is strongly suggested that the reader seek his or her own independent advice in relation to any investment, financial, legal, tax, accounting or regulatory risks and evaluate their own risk tolerance before investing.

This material does not constitute investment advice, nor does it constitute an offer in any product or strategy offered by Clarion Partners LLC or Clarion Partners Europe, and should not be viewed as a current or past recommendation to buy or sell any securities. Any specific investment referenced may or may not be held in a Clarion Partners client account. It should not be assumed that any investment, in any property or other asset, was or will be profitable.

All Clarion Partners LLC and Clarion Partners Europe statistics, data and charts, including but not limited to assets under management (AUM), ESG data, sector data and property data, as well as data related to our investors, tenants and employees, are as of December 31, 2025 unless otherwise noted.

Photos used in this website were selected based on visual appearance, are used for illustrative purposes only, and are not necessarily reflective of all the investments in a Clarion fund or portfolio or the investments a Clarion fund or portfolio will make in the future.

close

You are leaving www.clarionpartners.com and being directed to a new site.

You have selected a link that will take you away from the Clarion Partners website. Although we have verified the accuracy of this link from our website to a third party website, the content of the web pages may change without notice. We are not responsible for the content, views, or privacy policies of the third party website. Privacy and security policies of such site may differ from those practiced by Clarion Partners.

By clicking on the ACCEPT button below, you acknowledge the previous statement and will be taken to the linked site. If you want to remain at this site, select the DECLINE button.

Decline Accept